November 1, 2000
1 Min Read
Lonza Group
FAIR LAWN, N.J.--Lonza Group announced the Food and Drug Administration (FDA)approval of its L-carnitine L-tartrate production. During an inspection ofLonza's L-carnitine L-tartrate production last year, FDA confirmed that it foundno deviations from cGMP requirements, and have classified Lonza as an acceptablesupplier of bulk active pharmaceutical ingredients. Lonza's L-carnitine productsare free from D-carnitine, Kosher certified and fulfill all requirements underUSP and FCC. For more information, visit www.lonzagroup.com.
Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.
You May Also Like